Newsroom

TOP STORIES

Dr. Locke CAR T lab

Moffitt Treats First U.S. Patient with Newly FDA-Approved CAR-T Therapy

"We are proud to lead worldwide efforts in this next phase of CAR-T treatment for lymphoma patients and bring this critical innovation to as many patients as possible,” said Frederick Locke, M.D., vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy.


Brian Czerniecki, MD, Moffitt
Breast Cancer Vaccine Personalized

"I think it’s a potential game-changer because we’ve actually shown that people lose this specific immune response early in the process of breast cancer development," says Brian Czerniecki, M.D., the chair of the department of Breast Oncology.


Contact the Public Relations Team:

Kim Polacek, APR, CPRC
Research, Clinical Trials, Government, M2Gen/ORIEN
813-745-7408 Kim.Polacek@Moffitt.org

Steve Blanchard
Clinical, Diversity, Sports & Hospital Partnerships
813-745-1718 Steve.Blanchard@Moffitt.org

Sara Bondell
Clinical, Sports & Community Partnerships, Supportive Care
813-745-1353 Sara.Bondell@Moffitt.org

Nancy Gay, APR
Clinical, International Referrals, Nursing, Finance
813-745-7581 Nancy.Gay@Moffitt.org

Lisa Murphy
Foundation, Facilities, Pharmacy, IT
813-745-7497 Lisa.Murphy@Moffitt.org

Latest News

PRESS RELEASE ARCHIVE

2018
2017
2016
Older

MOFFITT IN THE NEWS

Newsweek Cover

2018
2017
2016

Older


TWITTER